Orion Corporation, Orion Pharma · 66-66 · FINLAND

For Orion Corporation, Orion Pharma, import alert is 66-66; country is FINLAND; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; product code is 61 U - - 05 Tamoxifen Citrate (Anti-Estrogen) | 62 I - - 30 Mercaptopurine (Anti-Neoplastic); date published is 09/30/2009; address is Orionintie 1 , Espoo, Helsinki-Uusimaa FINLAND, verified against its source on 2026-09-30.

What the source says

Orion Corporation, Orion Pharma Date Published : 09/30/2009 Orionintie 1 , Espoo, Helsinki-Uusimaa FINLAND 61 U - - 05 Tamoxifen Citrate (Anti-Estrogen) Date Published: 09/30/2009 Notes: 11/2/2000 62 I - - 30 Mercaptopurine (Anti-Neoplastic) Date Published: 09/30/2009 Notes: 11/2/2000

— accessdata.fda.gov, retrieved 2026-09-15

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

— all from accessdata.fda.gov, retrieved 2026-09-15

The same source also states

Orion Corporation, Orion Pharma Date Published : 09/30/2009 Orionintie 1 , Espoo, Helsinki-Uusimaa FINLAND 66 M - - 09 Buspirone HCl (Tranquilizer) Date Published: 09/30/2009 Notes: 11/2/2000

— accessdata.fda.gov, retrieved 2026-09-15

Source

• accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html

Last verified against source: 2026-09-30. Due for re-check by 2026-11-29. This page as Markdown · OKF bundle · full dataset as JSON.